Cullinan Therapeutics, Inc.
USD18.59
+0.17 (+0.92%)
CEO
Nadim Ahmed
IPO Date
2021-01-08
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Exchange
NASDAQ
Country
US
Open
$18.62
Prev. Close
$18.42
Day Low
$18.34
Day High
$18.82
52W Low
$5.68
52W High
$19.43
Market Cap
$1.14B
Volume
0.14M
| -3.9 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -33.8% | -31.6% | 0.01 | 17.07 | -2.8 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | 20.8% | 19.8% | 0.01 | 21.09 | 4.3 |
| 31 Dec 2021 | FY | 100.0% | -346.1% | -15.4% | -15.0% | 0.00 | 25.25 | -10.4 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -26.0% | -24.1% | 0.00 | 14.82 | -25.1 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | 49.1% | -19.9% | 0.00 | 39.67 | -1.5 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | 68.7% | -41.0% | 0.00 | 25.85 | -1.7 |
| -3.0 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -11.2% | -10.5% | 0.00 | 10.45 | -1.7 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -14.2% | -13.5% | 0.00 | 9.83 | -1.6 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -8.8% | -8.4% | 0.00 | 11.62 | -2.3 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -8.1% | -7.7% | 0.00 | 13.53 | -3.7 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -6.5% | -6.2% | 0.00 | 24.46 | -6.0 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -6.4% | -6.2% | 0.00 | 28.87 | -5.5 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -8.7% | -8.3% | 0.01 | 20.33 | -5.1 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -5.2% | -4.9% | 0.01 | 17.07 | -4.6 |